HomepageEducational Background
Residency
Emergency Medicine, University of Arizona Health Sciences Center, 1985 - 1987
Neurology, Columbia Presbyterian Medical Center, 1971 - 1974
Internship
Internal Medicine, Lenox Hill Hospital, 1970 - 1971
Medical
M.D., Georgetown University School of Medicine, 1970
Undergraduate
B.S., Brooklyn College, Brooklyn, NY, 1966
Memberships
Emergency Medicine, American Board of Emergency Medicine, 1988
Neurology, American Board of Psychiatry and Neurology, 1980
Professional Appointments
1972-1974 Research Assoc., Surgeon, U.S. Public Health Service, NIH, Bethesda,MD
1976-1978 Instructor in Clinical Neurology, Columbia University, NY, NY
1976-1978 Director, Pain Rehabilitation Service; Director, Pain Clinic; Department of Medicine, Helen Hayes Hospital, West Haverstraw, NY
1976-1978 Assistant Neurologist, Neurology Service, Presbyterian Hospital, NY, NY
1976-1980 Director, Neurological Services; Director, Neurology Clinic
1978 Associate Neurologist, Neurology Service, Presbyterian Hospital, NY, NY
1978-1979 Associate in Clinical Neurology, Columbia University, NY, NY
1978-1982 Assistant Attending Neurologist, Neurology Service, Presbyterian Hospital, NY, NY
1979-1982 Assistant Professor of Clinical Neurology, Columbia University, NY, NY
1980-1985 Executive Director, Physicians for Social Responsibility/NYC
1987-1995 Assistant Clinical Professor of Neurology, UCLA Medical Center
1987-1995 Assistant Clinical Professor of Medicine, Emergency Medicine Center, UCLA Medical Center
1989-1996 Faculty Member, Special Studies Medical Scientist Training Program, UCLA School of Medicine
1989- Faculty Advisor, Student Research Program, UCLA College of Arts and Sciences
1989-1990 Director, Emergency Medicine Residency Program, UCLA Medical Center
1995-1997 Chairman, Stroke Group, UCLA Stroke Center
1995-2001 Associate Professor of Neurology, UCLA Medical Center
1995-2001 Associate Professor of Medicine, Emergency Medicine Center, UCLA Medical Center
1995- Director, Emergency Neurology Program, UCLA Stroke Center
2001- Professor of Neurology, UCLA Medical Center
2001- Professor of Medicine, Emergency Medicine Center, UCLA
Medical Center
Selected Publications1. Ovbiagele B, Buck BH, Liebeskind DS, Starkman S, Bang OY, Ali LK, Villablanca JP, Salamon N, Yun SW, Pineda S, Saver JL. Prior antiplatelet use and infarct volume in ischemic stroke. J Neurol Sci. 264(1-2):140-4 (2008).
2. Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger J, Villablanca P, Saver JL. Diagnosis of lacunar infarcts within 6 hours of onset by clinical and CT criteria versus MRI. J Neuroimaging. 18(1):66-72 (2008).
3. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Razinia T, Ovbiagele B. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke. 39(2):355-60 (2008).
4. Kidwell CS, Latour L, Saver JL, Alger JR, Starkman S, Duckwiler G, Jahan R, Vinuela F, Kang DW, Warach S. Thrombolytic Toxicity: Blood Brain Barrier Disruption in Human Ischemic Stroke. Cerebrovasc Dis. 25(4):338-343 (2008).
5. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP. Mechanical Thrombectomy for Acute Ischemic Stroke. Final Results of the Multi MERCI Trial. Stroke. 2008 Feb 28; (2008).
6. Buck BH, Liebeskind DS, Saver JL, Bang OY, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Yun SW, Razinia T, Ovbiagele B. Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke. Arch Neurol. 64(9):1287-91 (2007).
7. Bang OY, Buck BH, Saver JL, Alger JR, Yoon SR, Starkman S, Ovbiagele B, Kim D, Ali LK, Sanossian N, Jahan R, Duckwiler GR, Vinuela F, Salamon N, Villablanca JP, Liebeskind DS. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol. 2007 Aug 7; (2007).
8. Viehman JA, Saver JL, Liebeskind DS, Starkman S, Ali LK, Buck B, Razinia T, Ovbiagele B. Utility of urinalysis in discriminating cardioembolic stroke mechanism. Arch Neurol. 64(5):667-70 (2007).
9. Ovbiagele B, Buck BH, Liebeskind DS, Starkman S, Bang OY, Ali LK, Villablanca JP, Salamon N, Yun SW, Pineda S, Saver JL. Prior antiplatelet use and infarct volume in ischemic stroke. J Neurol Sci. 2007 Sep 11; (2007).
10. Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, Kim D, Jahan R, Duckwiler GR, Yoon SR, Vinuela F, Liebeskind DS. Impact of collateral flow on tissue fate in acute ischemic stroke. J Neurol Neurosurg Psychiatry. 2007 Dec 20; (2007).
11. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Razinia T, Ovbiagele B. Early Neutrophilia Is Associated With Volume of Ischemic Tissue in Acute Stroke. Stroke. 2007 Dec 27; (2007).
12. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke. 37(8):2086-93 (2006).
13. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of Thrombi Retrieved From Cerebral Arteries of Patients With Acute Ischemic Stroke. Stroke. 2006 Jun 22; (2006).
14. Saver JL, Kidwell C, Eckstein M, Ovbiagele B, Starkman S. Physician-investigator phone elicitation of consent in the field: a novel method to obtain explicit informed consent for prehospital clinical research. Prehosp Emerg Care. 10(2):182-5 (2006).
15. Vespa P, McArthur D, Miller C, O'Phelan K, Frazee J, Kidwell C, Saver J, Starkman S, Martin N. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care. 2(3):274-81 (2005).
16. Suzuki S, Kidwell CS, Starkman S, Saver JL, Duckwiler G, Vinuela F, Ovbiagele B. Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. Stroke. 36(9):e77-9 (2005).
17. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 36(7):1432-8 (2005).
18. Suzuki S, Saver JL, Scott P, Jahan R, Duckwiler G, Starkman S, Su Y, Kidwell CS. Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. AJNR Am J Neuroradiol. 25(10):1802-6 (2004).
19. Saver JL, Kidwell C, Eckstein M, Starkman S. Intravenous Magnesium for Neuroprotection in Acute Stroke: Neuropharmacology Supports Clinical Hope. Response. Stroke. 2004 Oct 28; (2004).
20. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, Butman JA, Patronas N, Alger JR, Latour LL, Luby ML, Baird AE, Leary MC, Tremwel M, Ovbiagele B, Fredieu A, Suzuki S, Villablanca JP, Davis S, Dunn B, Todd JW, Ezzeddi. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 292(15):1823-30 (2004).
21. Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R, Pile-Spellman J, Segal A, Vinuela F, Saver JL. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke. 35(12):2848-54 (2004).
22. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke. 35(5):e106-8 (2004).
23. Llanes JN, Kidwell CS, Starkman S, Leary MC, Eckstein M, Saver JL. The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp Emerg Care. 8(1):46-50 (2004).
24. Ostrem JL, Saver JL, Alger JR, Starkman S, Leary MC, Duckwiler G, Jahan R, Vespa P, Villablanca JP, Gobin YP, Vinuela F, Kidwell CS. Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke. 35(2):e30-4 (2004).
25. Ferguson KN, Kidwell CS, Starkman S, Saver JL. Hyperacute treatment initiation in neuroprotective agent stroke trials. J Stroke Cerebrovasc Dis. 13(3):109-12 (2004).
26. Leary MC, Kidwell CS, Villablanca JP, Starkman S, Jahan R, Duckwiler GR, Gobin YP, Sykes S, Gough KJ, Ferguson K, Llanes JN, Masamed R, Tremwel M, Ovbiagele B, Vespa PM, Vinuela F, Saver JL. Validation of computed tomographic middle cerebral artery "dot"sign: an angiographic correlation study. Stroke. 34(11):2636-40 (2003).
27. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke. Curr Treat Options Cardiovasc Med. 5(6):441-449 (2003).
28. Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Villablanca JP, Vespa PM, Kidwell CS. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke. 34(6):1425-30 (2003).
29. Leary MC, Saver JL, Gobin YP, Jahan R, Duckwiler GR, Vinuela F, Kidwell CS, Frazee J, Starkman S. Beyond tissue plasminogen activator: mechanical intervention in acute stroke. Ann Emerg Med. 41(6):838-46 (2003).
30. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 3(1):9-20 (2003).
31. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, Leary MC, Starkman S, Gobin YP, Jahan R, Vespa P, Liebeskind DS, Alger JR, Vinuela F. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 33(1):95-8 (2002).
32. Kidwell CS, Saver JL, Carneado J, Sayre J, Starkman S, Duckwiler G, Gobin YP, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Vinuela F. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke. 33(3):717-24 (2002).
33. Kidwell CS, Saver JL, Starkman S, Duckwiler G, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Gobin YP, Vinuela F, Alger JR. Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol. 52(6):698-703 (2002).
34. Kidwell CS, Saver JL, Mattiello J, Warach S, Liebeskind DS, Starkman S, Vespa P, Vinuela F, Villablanca JP, Martin NA, Frazee J, Alger JR. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 57:1611-1617. (2001).
35. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Woods RP, Alger JR. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology. 57:2015-2021 (2001).
36. Kidwell CS, Liebeskind DS, Starkman S, Saver JL. Trends in ischemic stroke trials through the 20th century. Stroke. 32:1349-1359 (2001).
37. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, Leary MC, Starkman S, Gobin YP, Jahan R, Vespa P, Liebeskind DS, Alger JR, Vinuela F. MRI detection of microbleeds prior to thrombolysis: an emerging application. Stroke. 33:95-98 (2001).
38. Saver JL, Kidwell CS, Liebeskind DS, Starkman S. Acute ischemic stroke trials (Letter). Stroke. 32:275-8 (2001).
39. Kidwell CS, Saver JL, Mattiello J, Warach S, Liebeskind DS, Starkman S, Vespa P, Vinuela F, Villablanca JP, Martin NA, Frazee J, Alger JR. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 57:1611-1617 (2001).
40. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Woods RP, Alger JR. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology. 57:2015-2021 (2001).
41. Kidwell CS, Saver JL, Mattielo J, Warach S, Liebeskind D, Starkman S, Vespa PM, Martin NA, Villablanca JP, Frazee J, Alger JR. Diffusion-perfusion MRI evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 57:1611-1617 (2001).
42. Derex L, Tomsick TA, Brott TG, Lewandowski CA, Frankel MR, Clark W, Starkman S, Spilker J; Udsten GJ; Khoury J, Grotta JC, Broderick JP. Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. The EMS Bridging Trial Ajnr. American Journal of Neuroradiology. 22: 685-90 (2001).
43. Lee L, Kidwell C, Alger JR, Starkman S, Saver JL. Impact upon stroke subtype diagnosis of early diffusion weighted MRI and MR angiography. Stroke. 31:1081-1089 (2000).
44. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury shown by Diffusion/Perfusion Magnetic Resonance Imaging. Annals of Neurology. 47:462-9 (2000).
45. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin P, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Annals of Neurology. 47:462-469 (2000).
46. Kidwell CS, Saver JL, Starkman S. The acute stroke patient: prehospital stroke identification and treatment. In: Cohen SN, ed. Management of Ischemic Stroke. New York: McGraw-Hill. (2000).
47. Lee U, Kidwell CS, Alger JR, Starkman S, Saver JL. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke. 31:1081-1089 (2000).
48. Kidwell CS, Saver JL, Starkman S. Prehospital emergency stroke care. In: Cohen SN, ed. Management of Ischemic Stroke: A Clinical Approach. First ed. 3-16 (2000).
49. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin P, Jahan R Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Annals of Neurology. 47:462-469 (2000).
50. Lee U, Kidwell, Alger JR, Starkman S, Saver JL. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke. 31:1081-1089 (2000).
51. Kalafut MA, Schriger DL, Saver JL, Starkman S. Detection of early CT signs of > 1/3 middle cerebral artery infarctions: interrater reliability and sensitivity of CT interpretation by physicians involved in acute stroke care. Stroke. 31:1667-1671 (2000).
52. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke. 31:71-76 (2000).
